Persista Bio

Entry Date
October 2025

Description
The Persista Bio® O2Line™ system is a long-term cell implant that automatically regulates blood sugar like our pancreas does.

Company Website
https://www.persistabio.com/

CEO
Linda Templeman

Status
Current